转化式学习
制药工业
人工智能
过程(计算)
计算机科学
风险分析(工程)
人工智能应用
机器学习
医学
心理学
药理学
教育学
操作系统
作者
Aashveen Chhina,Karan Trehan,Muskaan Saini,Shubham Thakur,Manjot Kaur,Navid Reza Shahtaghi,Riya Shivgotra,B. K. Soni,Anuj Modi,Hossamaldeen Bakrey,Subheet Kumar Jain
标识
DOI:10.2174/1381612829666230807161421
摘要
This article explores the significant impact of artificial intelligence (AI) and machine learning (ML) on the pharmaceutical industry, which has transformed the drug development process. AI and ML technologies provide powerful tools for analysis, decision-making, and prediction by simplifying complex procedures from drug design to formulation design. These techniques could potentially speed up the development of better medications and drug development processes, improving the lives of millions of people. However, the use of these techniques requires trained personnel and human surveillance for AI to function effectively, if not there is a possibility of errors like security breaches of personal data and bias can also occur. Thus, the present review article discusses the transformative power of AI and ML in the pharmaceutical industry and provides insights into the future of drug development and patient care.
科研通智能强力驱动
Strongly Powered by AbleSci AI